Catalyst Pharmaceuticals: Q1 Earnings Insights

Catalyst Pharmaceuticals CPRX reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:07 PM.

Here's what investors need to know about the announcement.

Catalyst Pharmaceuticals beat estimated earnings by 28.12%, reporting an EPS of $0.41 versus an estimate of $0.32.

Revenue was up $42.28 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 9.83% increase in the share price the next day.

Here's a look at Catalyst Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0.21	0.19	0.17	0.14
EPS Actual	0.31	0.26	0.28	0.12
Revenue Estimate	58.09M	53.62M	49.21M	42.75M
Revenue Actual	60.76M	57.24M	53.11M	43.09M

To track all earnings releases for Catalyst Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar